 |
|
|
| |
Early Evidence of Antiviral Activity and Safety of
ABX464 in HIV Treatment-Naïve Patients
|
| |
| |
"Phase IIa trial in HIV/AIDS patients with drug candidate ABX464"....treatment/cure....
http://www.natap.org/2016/HIV/060116_02.htm
Reported by Jules Levin
2016 CROI
February 22-25, 2016,
Boston, MA Late Breaker Poster
Didier Scherrer 1, Jean-Marc Steens1, Supparatpinyo Kuanchai 2, Ratanasuwan Winai 3, Kiat Ruxrungtham4, Regine Rouzier 5, Jamal Tazi6, Paul Gineste1, Hartmut Ehrlich1, Robert Murphy7
1 ABIVAX, Paris, France; 2 Chiang Mai University, Chiang Mai, Thailand; 3 Siriraj Hospital, Bangkok, Thailand; 4 HIV-NAT, Chulalongkorn University Hospital, Bangkok, Thailand; 5 Cap Research, Phoenix, Mauritius; 6 University of Montpellier, Montpellier, France; 7 Northwestern University Feinberg School of Medicine, Chicago, USA
|
| |
|
|
|
|
|
